Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosso

Showing results (301-310 of 478) with videos related to

Pageof 48
Sort By:
Human Pathology|June 1, 1992
Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)M Paulli, R Rosso, S Kindl, et al.
American Journal of Clinical Oncology|February 1, 1990
5-Fluorouracil and high-dose folinic acid as second-line chemotherapy in head and neck cancerM Merlano, A Bacigalupo, M Benasso, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Adjuvant chemotherapy with cisplatin and cyclophosphamide in FIGO I-II epithelial carcinoma of the ovary: preliminary results]S Chiara, P F Conte, M Bruzzone, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Tumori|June 30, 1990
Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimensL Repetto, S Chiara, M Pace, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimensS Chiara, E Campora, L Merlini, et al.
Journal of the National Cancer Institute|March 19, 1997
Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minorL Del Mastro, M Venturini, M Costantini, et al.
Anticancer Research|July 1, 1989
Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposideA Ardizzoni, C Pennucci, V Fusco, et al.
Journal of Endocrinological Investigation|May 1, 1997
Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia type IV Carnevale, E Romagnoli, D Remotti, et al.
Oncology|January 1, 1987
Multimodality treatment of locally advanced breast cancerR Lionetto, P Pronzato, P F Conte, et al.
Pageof 48

Showing results (301-310 of 478) with videos related to

Sort By:
Pageof 48
Human Pathology|June 1, 1992
Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)M Paulli, R Rosso, S Kindl, et al.
American Journal of Clinical Oncology|February 1, 1990
5-Fluorouracil and high-dose folinic acid as second-line chemotherapy in head and neck cancerM Merlano, A Bacigalupo, M Benasso, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Adjuvant chemotherapy with cisplatin and cyclophosphamide in FIGO I-II epithelial carcinoma of the ovary: preliminary results]S Chiara, P F Conte, M Bruzzone, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Tumori|June 30, 1990
Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimensL Repetto, S Chiara, M Pace, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimensS Chiara, E Campora, L Merlini, et al.
Journal of the National Cancer Institute|March 19, 1997
Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minorL Del Mastro, M Venturini, M Costantini, et al.
Anticancer Research|July 1, 1989
Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposideA Ardizzoni, C Pennucci, V Fusco, et al.
Journal of Endocrinological Investigation|May 1, 1997
Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia type IV Carnevale, E Romagnoli, D Remotti, et al.
Oncology|January 1, 1987
Multimodality treatment of locally advanced breast cancerR Lionetto, P Pronzato, P F Conte, et al.
Pageof 48